Loyal Market Share Analysis for May 2026

Sometimes our dogs seem to read us like an open book! How do they know just how we are feeling? It turns out, our faces are a clear window into our emotions for our canine friends.

Pets and Animals > Pet Food and Supplies

Domainloyal.com

Year Founded2020

Employees51 - 200

Annual Revenue--

Loyal

Loyal (including company regionals)

loyal.com

See more website traffic and engagement information

Total visits to Loyal's top domains

Understand Loyal market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

loyal.com60.7K

See more with Sales Intelligence

Avg. visit duration in Loyal's top domains

Analyze Loyal engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

loyal.com00:00:17

See more with Sales Intelligence

Avg. pageviews on Loyal's top domains

See how Loyal keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

loyal.com1.84

See more with Sales Intelligence

Loyal top competitors by domain

Top similar sites in May 2026, ranked by their affinity

novavax.comCompany NameNovavaxEmployees501 - 1000HQUnited States, Maryland, GaithersburgAnnual revenue> $1BTotal visits32.4KFinance > Investing

Top technologies used by Loyal

These are the website technologies, by industry, used by Loyal top domains

Advertising (6)

Google Adsense

Audio Video Media (4)

YouTube

Conversion & Analytics (4)

Google Analytics

Payment & Currencies (4)

Visa

More Technologies

13

See all

News & Signals from Loyal

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLoyal is developing LOY-002.Loyal, the San Francisco biotech founded by Celine Halioua, is developing LOY-002 for dogs at least 10 years old and weighing 14 pounds or more, People reports.

NewsLoyal receives financing of $100M in Series A.* - Loyal secured $100M Series A to advance canine longevity drug.

NewsLoyal receives financing of $100M in Series C.Loyal, the clinical-stage animal health company developing what it hopes will become the first FDA-approved drug for lifespan extension, has raised $100 million in a Series C financing led by age1, the next generation of Laura Deming's Longevity Fund.